150 related articles for article (PubMed ID: 8839789)
1. Characterisation of a human endometrial adenocarcinoma established in vivo and in vitro.
Karlsson L; Leser G; Ryd W; Delle U; Köpf I; Horvath G
In Vivo; 1996; 10(4):421-8. PubMed ID: 8839789
[TBL] [Abstract][Full Text] [Related]
2. Estradiol induced changes in tumor growth and steroid receptor content in a heterotransplanted human endometrial adenocarcinoma.
Horvath G; Fernö M; Baldetorp B; Cameron R; Ranstam J
In Vivo; 1991; 5(4):401-6. PubMed ID: 1810429
[TBL] [Abstract][Full Text] [Related]
3. Estradiol regulates tumor growth by influencing p53 and bcl-2 expression in human endometrial adenocarcinomas grown in nude mice.
Horvath G; Leser G; Karlsson L; Delle U
In Vivo; 1996; 10(4):411-6. PubMed ID: 8839787
[TBL] [Abstract][Full Text] [Related]
4. Effect of estradiol on tumor growth, cell kinetics and p53 oncoprotein expression in human endometrial adenocarcinoma heterotransplanted into nude mice.
Horvath G; Baldetorp B; Fernö M; Johansson M; Nesland J; Tropé C
In Vivo; 1993; 7(5):451-6. PubMed ID: 8110990
[TBL] [Abstract][Full Text] [Related]
5. Estradiol influences p53 expression in a human endometrial adenocarcinoma heterotransplanted into nude mice.
Horvath G; Leser G; Delle U
In Vivo; 1996; 10(1):29-32. PubMed ID: 8726808
[TBL] [Abstract][Full Text] [Related]
6. Establishment and characterization of six new human endometrial adenocarcinoma cell lines.
Möbus V; Gerharz CD; Mitze M; Moll R; Pollow K; Kother T; Knapstein PG; Kreienberg R
Gynecol Oncol; 1993 Mar; 48(3):370-83. PubMed ID: 7681807
[TBL] [Abstract][Full Text] [Related]
7. Enhanced growth of an estrogen receptor-negative endometrial adenocarcinoma by estradiol in athymic mice.
Friedl A; Gottardis MM; Pink J; Buchler DA; Jordan VC
Cancer Res; 1989 Sep; 49(17):4758-64. PubMed ID: 2758409
[TBL] [Abstract][Full Text] [Related]
8. Progression of human endometrial adenocarcinoma heterotransplanted into nude mice from hormone-sensitive to hormone resistant growth.
Horvath G; Fernö M; Baldetorp B; Cameron R; Ranstam J
In Vivo; 1991; 5(2):185-90. PubMed ID: 1768790
[TBL] [Abstract][Full Text] [Related]
9. Isolation of a stromal cell line from an early passage of a mouse mammary tumor line: a model for stromal parenchymal interactions.
Lamb CA; Fabris V; Gorostiaga MA; Helguero LA; Efeyan A; Bottino MC; Simian M; Soldati R; Sanjuan N; Molinolo A; Lanari C
J Cell Physiol; 2005 Mar; 202(3):672-82. PubMed ID: 15389583
[TBL] [Abstract][Full Text] [Related]
10. Five novel hormone-responsive cell lines derived from murine mammary ductal carcinomas: in vivo and in vitro effects of estrogens and progestins.
Lanari C; Lüthy I; Lamb CA; Fabris V; Pagano E; Helguero LA; Sanjuan N; Merani S; Molinolo AA
Cancer Res; 2001 Jan; 61(1):293-302. PubMed ID: 11196177
[TBL] [Abstract][Full Text] [Related]
11. [Effects of female sex steroid hormones on human endometrial adenocarcinoma transplanted into nude mice].
Miyawaki Y
Nihon Gan Chiryo Gakkai Shi; 1989 Dec; 24(11):2607-16. PubMed ID: 2614195
[TBL] [Abstract][Full Text] [Related]
12. Estradiol induces DNA fragmentation in a human endometrial adenocarcinoma with estradiol-inhibited growth phenotype.
Karlsson L; Leser G; Ryd W; Horvath G
Anticancer Res; 1997; 17(5A):3259-63. PubMed ID: 9413157
[TBL] [Abstract][Full Text] [Related]
13. Estrogen receptor activation in relation to previous estrogen treatment in carcinoma corporis uteri heterotransplanted into nude mice.
Horvath G; Fernö M; Cameron R; Ranstam J
In Vivo; 1989; 3(2):93-7. PubMed ID: 2519844
[TBL] [Abstract][Full Text] [Related]
14. Growth interaction between different tumor populations in human endometrial adenocarcinoma growing in nude mice.
Horvath G; Fernö M; Baldetorp B; Johansson M
In Vivo; 1993; 7(6A):511-7. PubMed ID: 8193269
[TBL] [Abstract][Full Text] [Related]
15. A metastatic breast tumor cell line, GI-101A, is estrogen receptor positive and responsive to estrogen but resistant to tamoxifen.
Morrissey JJ; Raney S
Cell Biol Int; 1998; 22(6):413-9. PubMed ID: 10328849
[TBL] [Abstract][Full Text] [Related]
16. Protein expression of p53 and Rb suppressor genes during the first passages of human endometrial adenocarcinomas heterotransplanted into nude mice.
Horvath G; Leser G; Delle U
In Vivo; 1995; 9(1):41-8. PubMed ID: 7669947
[TBL] [Abstract][Full Text] [Related]
17. New human hepatocellular carcinoma (HCC) cell line with highly metastatic potential (MHCC97) and its expressions of the factors associated with metastasis.
Tian J; Tang ZY; Ye SL; Liu YK; Lin ZY; Chen J; Xue Q
Br J Cancer; 1999 Nov; 81(5):814-21. PubMed ID: 10555751
[TBL] [Abstract][Full Text] [Related]
18. [Effects of CPUY013, a novel Topo I inhibitor, on human gastric adenocarcinoma BGC823 cells in vitro and in vivo].
Ji YB; Zhou JH; Zuo MX; You QD
Yao Xue Xue Bao; 2008 Aug; 43(8):811-8. PubMed ID: 18956773
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of tumor-associated fatty acid synthase activity antagonizes estradiol- and tamoxifen-induced agonist transactivation of estrogen receptor (ER) in human endometrial adenocarcinoma cells.
Menendez JA; Oza BP; Atlas E; Verma VA; Mehmi I; Lupu R
Oncogene; 2004 Jun; 23(28):4945-58. PubMed ID: 15094777
[TBL] [Abstract][Full Text] [Related]
20. A significance of immunohistochemical determination of steroid receptors, cell proliferation factor Ki-67 and protein p53 in endometrial carcinoma.
Oreskovic S; Babic D; Kalafatic D; Barisic D; Beketic-Oreskovic L
Gynecol Oncol; 2004 Apr; 93(1):34-40. PubMed ID: 15047211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
